학술논문

Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy
Document Type
Report
Source
Biomarkers in Medicine. June 2014, Vol. 8 Issue 5, p641, 12 p.
Subject
Blood tests -- Innovations
Muscular diseases -- Development and progression -- Genetic aspects
Biological markers -- Identification and classification
Health
Identification and classification
Development and progression
Innovations
Genetic aspects
Language
English
ISSN
1752-0363
Abstract
Aim: The exact pathomechanism of GNE myopathy remains elusive, but likely involves aberrant sialylation. We explored sialylation status of blood-based glycans as potential disease markers. Methods: We employed immunoblotting, lectin histochemistry and mass spectrometry. Results: GNE myopathy muscle showed hyposialylation of predominantly O-linked glycans. The O-linked glycome of patients' plasma compared with controls showed increased amounts of desialylated Thomsen-Friedenreich (T)-antigen, and/or decreased amounts of its sialylated form, ST-antigen. Importantly, all patients had increased T/ST ratios compared with controls. These ratios were normalized in a patient treated with intravenous immunoglobulins as a source of sialic acid. Discussion: GNE myopathy clinical trial data will reveal whether T/ST ratios correlate to muscle function. Conclusion: Plasma T/ST ratios are a robust blood-based biomarker for GNE myopathy, and may also help explain the pathology and course of the disease.
Author(s): Petcharat Leoyklang [sup.aff1] , May Christine Malicdan [sup.aff1] , Tal Yardeni [sup.aff1] [sup.aff2] , Frank Celeste [sup.aff3] , Carla Ciccone [sup.aff1] , Xueli Li [sup.aff4] [sup.aff5] , Rong Jiang [...]